GA in Evaluation of Diabetes Control
CEAAA
International Wheat Yield Partnership
Transforming Correlative Science to Predictive Personalized Medicine Richard Simon, D.Sc. National Cancer Institute .
Impact of the results of large genetic field experimental networks to practical forestry supporting industry. Dag Lindgren Presentation 100622 at TREEBREEDEX.
Rapid Learning Precision Oncology. Part I: Patient’s Perspective Part II: Industry Perspective Part III: Aligning Incentives.
The Cochrane Reviews of Acupuncture Doris Hubbs, MD, FACP April 26, 2013.
Randomising every patient you see: Software for clinic seat research Bruce Arroll Douglas Kingsford Antonio Fernando III 2010 Department of General Practice.
Recent Advances in Preventive Cardiology and Lifestyle Medicine Barry A. Franklin, Ph.D., FAHA Beaumont Health System Royal Oak, Michigan e-mail: [email protected].
Hypertension in patients with Type 2 Diabetes Mellitus – why are we failing to meet the targets? Walter van der Merwe Renal Physician, North Shore Hospital.
NO16968: XELOXA Adjuvant Treatment with Capecitabine and Oxaliplatin (XELOX) in Stage III Colon Cancer ESMO/ECCO Presidential Session III D. Haller, J.
Subgroup Analysis “Fun to look at but don’t believe them!” (P Sleight, 2000) Deciding on analysis after looking at the data is “dangerous, useful, and.
